共 50 条
- [1] Concomitant tacrolimus (TAC) and methotrexate (MTX) pharmacokinetics (PK) in rheumatoid arthritis (RA) patients. [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1053 - 1053
- [2] EFFECTS OF ETODOLAC ON METHOTREXATE (MTX) PHARMACOKINETICS IN RHEUMATOID-ARTHRITIS (RA) PATIENTS [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S343 - S343
- [3] Pharmacokinetics (PK) of etanercept are unaltered by concurrent administration of methotrexate (MTX) in rheumatoid arthritis (RA) patients. [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S139 - S139
- [5] Folic acid alters methotrexate (MTX) disposition in rheumatoid arthritis (RA) patients. [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S76 - S76
- [7] CLINICAL AND IMMUNOLOGICAL EFFECTS OF METHOTREXATE (MTX) IN RHEUMATOID-ARTHRITIS (RA) [J]. CLINICAL RESEARCH, 1984, 32 (02): : A661 - A661
- [8] Treatment of interleukin-1 receptor antagonist in combination with methotrexate (MTX) in rheumatoid arthritis (RA) patients. [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S273 - S273
- [10] ASSOCIATION OF METHOTREXATE (MTX) AND STEROIDS IN THE TREATMENT OF RHEUMATOID-ARTHRITIS (RA) PATIENTS [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 1280 - 1280